Press Releases

PDF viewPrint viewRSS FeedsEmail AlertSocial Media Sharing

Press ReleasesMore Press Releases...
1/13/2015Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market
12/19/2014Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract and Complicated Intra-abdominal Infections
12/08/2014Cubist Comments on CUBICIN Patent Litigation
11/17/2014European Antibiotic Awareness Day Highlights Need for Urgent Action
11/05/2014Cubist Names Dr. Patrick Vink Chief Operating Officer
11/03/2014Cubist to Present at Jefferies 2014 Healthcare Conference
10/21/2014Cubist Reports Third Quarter 2014 Financial Results
10/20/2014Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer
10/14/2014Cubist to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014
10/08/2014Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014
9/30/2014Cubist to Present New Data on Antibiotics Portfolio at IDWeek 2014
9/18/2014Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich
 Source: SNL Financial LC
Optimer Press Releases
8/1/2013 Optimer Reports Second Quarter 2013 Financial Results
5/9/2013 Optimer Reports First Quarter 2013 Financial Results
4/26/2013 DIFICID® (fidaxomicin) Tablets Approved in Australia
2/28/2013 Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
More Optimer Press Releases...

Trius Press Releases
6/12/2013 Trius Therapeutics Announces Publication of Antibiotic Safety Study in Antimicrobial Agents and Chemotherapy
5/13/2013 Trius Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin
4/29/2013 Trius Therapeutics Presents Clinical Data on Experimental Antibiotic Tedizolid at ECCMID Meeting
4/23/2013 Trius Therapeutics to Present Experimental Antibiotic Study Results at ECCMID Meeting
More Trius Press Releases...

Copyright 2015, © SNL Financial LC  Terms of Use